Researchers Submit Patent Application, "Compositions And Methods For The Treatment Of Neurological Disorders", for Approval (USPTO 20230364102).
In: Gene Therapy Weekly, 2023-12-04, S. 4155-4155
serialPeriodical
Zugriff:
A patent application has been submitted for the treatment of neurological disorders, specifically focusing on Parkinson's disease (PD). The application proposes the use of an ATM inhibitor to treat PD, particularly in individuals who express a variant form of the leucine-rich repeat kinase 2 (LRRK2) protein. Mitochondrial dysfunction and DNA damage are believed to play a role in the development of PD, and the application suggests that the ATM inhibitor could help rescue LRRK2 genome stability. The patent application also includes a kit for detecting the LRRK2 variant protein in biological samples. This research aims to address the urgent need for disease-modifying therapies for PD. [Extracted from the article]
Copyright of Gene Therapy Weekly is the property of NewsRx and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
Titel: |
Researchers Submit Patent Application, "Compositions And Methods For The Treatment Of Neurological Disorders", for Approval (USPTO 20230364102).
|
---|---|
Zeitschrift: | Gene Therapy Weekly, 2023-12-04, S. 4155-4155 |
Veröffentlichung: | 2023 |
Medientyp: | serialPeriodical |
ISSN: | 1078-2842 (print) |
Schlagwort: |
|
Sonstiges: |
|